[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @RheumNow Dr. John Cush Dr. John Cush posts on X about $abbv, ra, longterm, poster the most. They currently have XXXXXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours. ### Engagements: XXX [#](/creator/twitter::279184000/interactions)  - X Week XXXXX +20% - X Month XXXXXX -XX% - X Months XXXXXXX +1.40% - X Year XXXXXXX +75% ### Mentions: X [#](/creator/twitter::279184000/posts_active)  - X Week XX +9.10% - X Month XX -XX% - X Months XXX +38% - X Year XXX +163% ### Followers: XXXXXX [#](/creator/twitter::279184000/followers)  - X Week XXXXXX +0.19% - X Month XXXXXX +0.73% - X Months XXXXXX +4.50% - X Year XXXXXX +7.60% ### CreatorRank: XXXXXXXXX [#](/creator/twitter::279184000/influencer_rank)  ### Social Influence [#](/creator/twitter::279184000/influence) --- **Social category influence** [stocks](/list/stocks) XXXX% **Social topic influence** [$abbv](/topic/$abbv) #32, [ra](/topic/ra) 1.72%, [longterm](/topic/longterm) 1.72%, [poster](/topic/poster) 1.29%, [patterns](/topic/patterns) 0.86%, [ip](/topic/ip) #421, [ast](/topic/ast) 0.43%, [linked](/topic/linked) 0.43%, [psa](/topic/psa) XXXX% **Top accounts mentioned or mentioned by** [@yuz6yusof](/creator/undefined) [@illiasulk](/creator/undefined) [@lesai_bot](/creator/undefined) [@janetbirdope](/creator/undefined) [@adelacastro222](/creator/undefined) [@drdavidliew](/creator/undefined) [@12](/creator/undefined) [@24](/creator/undefined) [@lastmanstand85](/creator/undefined) [@drminidey](/creator/undefined) [@ssnaushon](/creator/undefined) [@mcp](/creator/undefined) [@eularorg](/creator/undefined) [@drinaya24330363](/creator/undefined) [@connollyrheum](/creator/undefined) [@synovialjoints](/creator/undefined) [@aprice1985](/creator/undefined) [@jiharheum](/creator/undefined) [@bella_mehta](/creator/undefined) [@nkomoru1989](/creator/undefined) **Top assets mentioned** [AbbVie Inc (ABBV)](/topic/$abbv) ### Top Social Posts [#](/creator/twitter::279184000/posts) --- Top posts by engagements in the last XX hours "NEW EULAR POSTER: Real-world treatment patterns across the first XX months of first-line advanced therapy in patients with PsA Compare treatment switching across first-line MOAs and treatments. Sponsored by AbbVie Medical Affairs + Health Impact" [X Link](https://x.com/RheumNow/status/1975607215173029955) [@RheumNow](/creator/x/RheumNow) 2025-10-07T17:00Z 24.6K followers, XXX engagements "A JAKi in RA: Explore the Data Guide ð Dr. Curtis and Dr. Winthrop share best practices for preparing to discuss risk in RA including a new long-term efficacy and safety data visualization tool. Sponsored by AbbVie Medical Affairs + Health Impact" [X Link](https://x.com/RheumNow/status/1978506224090923512) [@RheumNow](/creator/x/RheumNow) 2025-10-15T17:00Z 24.7K followers, XXX engagements "FDA has approved nerandomilast (PDE4b inhibitor) for treatment of adults with idiopathic pulmonary fibrosis (IPF). Approval is based on X RCTs FIBRONEER-IPF & FIBRONEER-ILD that show slowing of lung function decline IP & progressive pulmonary fibrosis (PPF) pts" [X Link](https://x.com/RheumNow/status/1975935146504102304) [@RheumNow](/creator/x/RheumNow) 2025-10-08T14:43Z 24.7K followers, 2796 engagements "Pregnancy Management in Inflammatory Bowel Disease: A Global Consensus Consensus guidance on the management of pregnancy in patients with inflammatory bowel disease (IBD) was simultaneously published in six international journals including The American Journal of Gastroenterology" [X Link](https://x.com/RheumNow/status/1978931700299120967) [@RheumNow](/creator/x/RheumNow) 2025-10-16T21:10Z 24.7K followers, XXX engagements "ðŽA JAKi CHAT: Shared Decision-Making in RA Dr. Curtis and Dr. Winthrop discuss approaches to patient conversations on risk with uncontrolled RA and treatment considerations including JAKi safety. Sponsored by AbbVie Medical Affairs + Health Impact" [X Link](https://x.com/RheumNow/status/1976309260452553166) [@RheumNow](/creator/x/RheumNow) 2025-10-09T15:30Z 24.6K followers, XXX engagements "FDA has approved nerandomilast (PDE4b inhibitor) for treatment of adults with idiopathic pulmonary fibrosis (IPF). Approval is based on X RCTs FIBRONEER-IPF & FIBRONEER-ILD that show slowing of lung function decline IP & progressive pulmonary fibrosis (PPF) pts" [X Link](https://x.com/RheumNow/status/1977373746378707056) [@RheumNow](/creator/x/RheumNow) 2025-10-12T14:00Z 24.7K followers, 9072 engagements "ð PRESENTED AT EULAR 2025: Long-term safety of a JAKi ð View safety across 17000 patient-years of data from XX Phase X trials in adult patients with RA PsA AS or nr-axSpA. This poster is sponsored by AbbVie Medical Affairs + Health Impact" [X Link](https://x.com/RheumNow/status/1978823498068853224) [@RheumNow](/creator/x/RheumNow) 2025-10-16T14:01Z 24.7K followers, XXX engagements "Muscle mass & JAKi XX active RA pts (+ sarcopenia risk) Rx w/ tofacitinib - signif. improved @1 mo. @6 mos muscle mass signif improved (+242 cm3 +4% p=0017) less w/ NSAIDs); w/ signif creatinine incr (0.06 mg/dl) & decr in serum IL-6 IL-1 & TNF. No change in CK myoglobin LDH AST" [X Link](https://x.com/RheumNow/status/1978974558964105444) [@RheumNow](/creator/x/RheumNow) 2025-10-17T00:01Z 24.7K followers, XXX engagements "Fibromyalgia in PsO & PsA is linked to greater treatment complexity and shorter biologic therapy survival. Retro matched 1:4 cohort study 61K PsO& 244K controls. FM prevalence XXX% (OR 1.45). In PsA decr biologic survival (6 vs 10yrs) w/ incr switching (HR 1.82)" [X Link](https://x.com/RheumNow/status/1977811688247173367) [@RheumNow](/creator/x/RheumNow) 2025-10-13T19:00Z 24.7K followers, 1685 engagements "ð NEW FROM EULAR: Real-world effectiveness of switching to a JAKi after first-line TNFi in PsA See how second-line treatment choices impacted TJC and SJC in patients from the Adelphi database. Poster sponsored by AbbVie Medical Affairs + Health Impact" [X Link](https://x.com/RheumNow/status/1978098634290819275) [@RheumNow](/creator/x/RheumNow) 2025-10-14T14:00Z 24.6K followers, XXX engagements "A JAKi in RA: Explore the Data Guide ð Dr. Curtis and Dr. Winthrop share best practices for preparing to discuss risk in RA including a new long-term efficacy and safety data visualization tool. Sponsored by AbbVie Medical Affairs + Health Impact" [X Link](https://x.com/RheumNow/status/1977041674892128284) [@RheumNow](/creator/x/RheumNow) 2025-10-11T16:00Z 24.6K followers, XXX engagements "ð NEW FROM EULAR: How many patients with PsA switch from their first-line treatment in the first year ð Explore real-world switching patterns among PsA patients on first-line advanced therapies. Sponsored by AbbVie Medical Affairs + Health Impact" [X Link](https://x.com/RheumNow/status/1976671623076868483) [@RheumNow](/creator/x/RheumNow) 2025-10-10T15:30Z 24.6K followers, XXX engagements "A JAKi in RA: Explore the Data Guide ð Dr. Curtis and Dr. Winthrop share best practices for preparing to discuss risk in RA including a new long-term efficacy and safety data visualization tool. Sponsored by AbbVie Medical Affairs + Health Impact" [X Link](https://x.com/RheumNow/status/1975199396686922152) [@RheumNow](/creator/x/RheumNow) 2025-10-06T14:00Z 24.6K followers, XXX engagements "ð PRESENTED AT EULAR 2025: Long-term safety of a JAKi ð View safety across 17000 patient-years of data from XX Phase X trials in adult patients with RA PsA AS or nr-axSpA. This poster is sponsored by AbbVie Medical Affairs + Health Impact" [X Link](https://x.com/RheumNow/status/1973216911497240930) [@RheumNow](/creator/x/RheumNow) 2025-10-01T02:42Z 24.6K followers, XXX engagements "Scientific American takes a look at the beneficial effects of: Omega-3 Fatty Acids Vitamin D Curcumin (basic overview for all)" [X Link](https://x.com/RheumNow/status/1978589252624511235) [@RheumNow](/creator/x/RheumNow) 2025-10-15T22:30Z 24.7K followers, 1093 engagements "Small XX pt. RCT found that 16-wks of Mediterranean diet signif improved psoriasis PASI scores. Intervention grp had better PASI change at week XX (3.4 vs 0) PASI XX and reducted hemoglobin A1c. Diet as adjunctive Rx in PsO" [X Link](https://x.com/RheumNow/status/1973878200728973338) [@RheumNow](/creator/x/RheumNow) 2025-10-02T22:30Z 24.7K followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@RheumNow Dr. John Cush
Dr. John Cush posts on X about $abbv, ra, longterm, poster the most. They currently have XXXXXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.
Engagements: XXX #
- X Week XXXXX +20%
- X Month XXXXXX -XX%
- X Months XXXXXXX +1.40%
- X Year XXXXXXX +75%
Mentions: X #
- X Week XX +9.10%
- X Month XX -XX%
- X Months XXX +38%
- X Year XXX +163%
Followers: XXXXXX #
- X Week XXXXXX +0.19%
- X Month XXXXXX +0.73%
- X Months XXXXXX +4.50%
- X Year XXXXXX +7.60%
CreatorRank: XXXXXXXXX #
Social Influence #
Social category influence stocks XXXX%
Social topic influence $abbv #32, ra 1.72%, longterm 1.72%, poster 1.29%, patterns 0.86%, ip #421, ast 0.43%, linked 0.43%, psa XXXX%
Top accounts mentioned or mentioned by @yuz6yusof @illiasulk @lesai_bot @janetbirdope @adelacastro222 @drdavidliew @12 @24 @lastmanstand85 @drminidey @ssnaushon @mcp @eularorg @drinaya24330363 @connollyrheum @synovialjoints @aprice1985 @jiharheum @bella_mehta @nkomoru1989
Top assets mentioned AbbVie Inc (ABBV)
Top Social Posts #
Top posts by engagements in the last XX hours
"NEW EULAR POSTER: Real-world treatment patterns across the first XX months of first-line advanced therapy in patients with PsA Compare treatment switching across first-line MOAs and treatments. Sponsored by AbbVie Medical Affairs + Health Impact"
X Link @RheumNow 2025-10-07T17:00Z 24.6K followers, XXX engagements
"A JAKi in RA: Explore the Data Guide ð Dr. Curtis and Dr. Winthrop share best practices for preparing to discuss risk in RA including a new long-term efficacy and safety data visualization tool. Sponsored by AbbVie Medical Affairs + Health Impact"
X Link @RheumNow 2025-10-15T17:00Z 24.7K followers, XXX engagements
"FDA has approved nerandomilast (PDE4b inhibitor) for treatment of adults with idiopathic pulmonary fibrosis (IPF). Approval is based on X RCTs FIBRONEER-IPF & FIBRONEER-ILD that show slowing of lung function decline IP & progressive pulmonary fibrosis (PPF) pts"
X Link @RheumNow 2025-10-08T14:43Z 24.7K followers, 2796 engagements
"Pregnancy Management in Inflammatory Bowel Disease: A Global Consensus Consensus guidance on the management of pregnancy in patients with inflammatory bowel disease (IBD) was simultaneously published in six international journals including The American Journal of Gastroenterology"
X Link @RheumNow 2025-10-16T21:10Z 24.7K followers, XXX engagements
"ðŽA JAKi CHAT: Shared Decision-Making in RA Dr. Curtis and Dr. Winthrop discuss approaches to patient conversations on risk with uncontrolled RA and treatment considerations including JAKi safety. Sponsored by AbbVie Medical Affairs + Health Impact"
X Link @RheumNow 2025-10-09T15:30Z 24.6K followers, XXX engagements
"FDA has approved nerandomilast (PDE4b inhibitor) for treatment of adults with idiopathic pulmonary fibrosis (IPF). Approval is based on X RCTs FIBRONEER-IPF & FIBRONEER-ILD that show slowing of lung function decline IP & progressive pulmonary fibrosis (PPF) pts"
X Link @RheumNow 2025-10-12T14:00Z 24.7K followers, 9072 engagements
"ð PRESENTED AT EULAR 2025: Long-term safety of a JAKi ð View safety across 17000 patient-years of data from XX Phase X trials in adult patients with RA PsA AS or nr-axSpA. This poster is sponsored by AbbVie Medical Affairs + Health Impact"
X Link @RheumNow 2025-10-16T14:01Z 24.7K followers, XXX engagements
"Muscle mass & JAKi XX active RA pts (+ sarcopenia risk) Rx w/ tofacitinib - signif. improved @1 mo. @6 mos muscle mass signif improved (+242 cm3 +4% p=0017) less w/ NSAIDs); w/ signif creatinine incr (0.06 mg/dl) & decr in serum IL-6 IL-1 & TNF. No change in CK myoglobin LDH AST"
X Link @RheumNow 2025-10-17T00:01Z 24.7K followers, XXX engagements
"Fibromyalgia in PsO & PsA is linked to greater treatment complexity and shorter biologic therapy survival. Retro matched 1:4 cohort study 61K PsO& 244K controls. FM prevalence XXX% (OR 1.45). In PsA decr biologic survival (6 vs 10yrs) w/ incr switching (HR 1.82)"
X Link @RheumNow 2025-10-13T19:00Z 24.7K followers, 1685 engagements
"ð NEW FROM EULAR: Real-world effectiveness of switching to a JAKi after first-line TNFi in PsA See how second-line treatment choices impacted TJC and SJC in patients from the Adelphi database. Poster sponsored by AbbVie Medical Affairs + Health Impact"
X Link @RheumNow 2025-10-14T14:00Z 24.6K followers, XXX engagements
"A JAKi in RA: Explore the Data Guide ð Dr. Curtis and Dr. Winthrop share best practices for preparing to discuss risk in RA including a new long-term efficacy and safety data visualization tool. Sponsored by AbbVie Medical Affairs + Health Impact"
X Link @RheumNow 2025-10-11T16:00Z 24.6K followers, XXX engagements
"ð NEW FROM EULAR: How many patients with PsA switch from their first-line treatment in the first year ð Explore real-world switching patterns among PsA patients on first-line advanced therapies. Sponsored by AbbVie Medical Affairs + Health Impact"
X Link @RheumNow 2025-10-10T15:30Z 24.6K followers, XXX engagements
"A JAKi in RA: Explore the Data Guide ð Dr. Curtis and Dr. Winthrop share best practices for preparing to discuss risk in RA including a new long-term efficacy and safety data visualization tool. Sponsored by AbbVie Medical Affairs + Health Impact"
X Link @RheumNow 2025-10-06T14:00Z 24.6K followers, XXX engagements
"ð PRESENTED AT EULAR 2025: Long-term safety of a JAKi ð View safety across 17000 patient-years of data from XX Phase X trials in adult patients with RA PsA AS or nr-axSpA. This poster is sponsored by AbbVie Medical Affairs + Health Impact"
X Link @RheumNow 2025-10-01T02:42Z 24.6K followers, XXX engagements
"Scientific American takes a look at the beneficial effects of: Omega-3 Fatty Acids Vitamin D Curcumin (basic overview for all)"
X Link @RheumNow 2025-10-15T22:30Z 24.7K followers, 1093 engagements
"Small XX pt. RCT found that 16-wks of Mediterranean diet signif improved psoriasis PASI scores. Intervention grp had better PASI change at week XX (3.4 vs 0) PASI XX and reducted hemoglobin A1c. Diet as adjunctive Rx in PsO"
X Link @RheumNow 2025-10-02T22:30Z 24.7K followers, XXX engagements